Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07574177
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiovascular HealthUniversity of South AlabamaNot Yet RecruitingNot Applicable
NCT07574177Not Yet Recruiting
Not Applicable
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiova...University of South Alaba...
NCT07574138
Function of Beta Cells in Early-onset Diabetes MellitusUniversity Medical Center Ho Chi Minh City (UMC)Recruiting
NCT07574138Recruiting
—
Function of Beta Cells in Early-onset Diabetes MellitusUniversity Medical Center...
NCT07572266
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Human and Machine CognitionNot Yet RecruitingNot Applicable
NCT07572266Not Yet Recruiting
Not Applicable
Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older AdultsFlorida Institute for Hum...
NCT07573163
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa SadaNot Yet RecruitingPhase 2
NCT07573163Not Yet Recruiting
Phase 2
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa Sada
NCT07573917
Improving Insulin Sensitivity in Patients With Type 2 Diabetes Via Repeated Cold-induced Shivering ThermogenesisMaastricht University Medical CenterRecruitingNot Applicable
NCT07573917Recruiting
Not Applicable
Improving Insulin Sensitivity in Patients With Type 2 Diabetes Via Repeated Cold...Maastricht University Med...
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07572032
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyAjou University Medical CenterNot Yet RecruitingPhase 4
NCT07572032Not Yet Recruiting
Phase 4
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology...Ajou University Medical C...
NCT07573540
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Not Yet RecruitingNot Applicable
NCT07573540Not Yet Recruiting
Not Applicable
Optimizing Smart Technology for Addiction RecoveryNational Institute on Alc...
NCT07571954
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center Prospective StudyiVascular S.L.U.Not Yet RecruitingNot Applicable
NCT07571954Not Yet Recruiting
Not Applicable
Evaluation of iNstroke 5F Aspiration Catheters for Thrombectomy: a Multi-center...iVascular S.L.U.
NCT07573449
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPhase 1
NCT07573449Completed
Phase 1
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Si...Otsuka Pharmaceutical Dev...
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07573228
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 DiabetesUniversity of VirginiaRecruitingNot Applicable
NCT07573228Recruiting
Not Applicable
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness...University of Virginia
NCT07572448
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sense Of SafetyUludag UniversityNot Yet Recruiting
NCT07572448Not Yet Recruiting
—
The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sens...Uludag University
NCT07572604
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Not Yet RecruitingNot Applicable
NCT07572604Not Yet Recruiting
Not Applicable
Community Health Worker Assessment for Postpartum HealthEunice Kennedy Shriver Na...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07574294
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca TrevigianaCompleted
NCT07574294Completed
—
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca Trev...
NCT07574359
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes in the Russian PopulationPirogov Russian National Research Medical UniversityRecruiting
NCT07574359Recruiting
—
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes...Pirogov Russian National...
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyBioMarin PharmaceuticalEnrolling By InvitationPhase 2
NCT07573631Enrolling By Invitation
Phase 2
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of B...BioMarin Pharmaceutical
NCT07572825
Assessing the Safety and Tolerability of NMN in DHDDS-CDGEva Morava-KoziczNot Yet RecruitingPhase 1
NCT07572825Not Yet Recruiting
Phase 1
Assessing the Safety and Tolerability of NMN in DHDDS-CDGEva Morava-Kozicz
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 14 (20%)
Phase 22 (10%)
Phase 41 (5%)